204 related articles for article (PubMed ID: 35406766)
1. The Inhibitory Effect of Selected D
Kasica N; Święch A; Saładziak K; Mackiewicz J; Osęka M
Cells; 2022 Apr; 11(7):. PubMed ID: 35406766
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats.
Miyagi M; Itoh F; Taya F; Arai N; Isaji M; Kojima M; Ujiie A
Biol Pharm Bull; 1996 Sep; 19(9):1210-3. PubMed ID: 8889042
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Ohta K; Kuno S; Mizuta I; Fujinami A; Matsui H; Ohta M
Life Sci; 2003 Jun; 73(5):617-26. PubMed ID: 12770616
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.
Wu YC; Chang CY; Kao A; Hsi B; Lee SH; Chen YH; Wang IJ
PLoS One; 2015; 10(5):e0126750. PubMed ID: 25978439
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF.
Merrigan SL; Kennedy BN
Br J Pharmacol; 2017 Aug; 174(16):2636-2651. PubMed ID: 28547797
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of three dopamine receptor agonists in MPTP-treated monkeys.
Arai N; Isaji M; Miyata H; Fukuyama J; Mizuta E; Kuno S
J Neural Transm Park Dis Dement Sect; 1995; 10(1):55-62. PubMed ID: 8619909
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy.
Cao R; Jensen LD; Söll I; Hauptmann G; Cao Y
PLoS One; 2008 Jul; 3(7):e2748. PubMed ID: 18648503
[TBL] [Abstract][Full Text] [Related]
8. A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
Butler CT; Reynolds AL; Tosetto M; Dillon ET; Guiry PJ; Cagney G; O'Sullivan J; Kennedy BN
J Biol Chem; 2017 Mar; 292(9):3552-3567. PubMed ID: 28035003
[TBL] [Abstract][Full Text] [Related]
9. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Kvernmo T; Härtter S; Burger E
Clin Ther; 2006 Aug; 28(8):1065-1078. PubMed ID: 16982285
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic activity of sarpogrelate and dopamine D
Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R
BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis.
Mendoza-Torreblanca JG; Cárdenas-Rodríguez N; Carro-Rodríguez J; Contreras-García IJ; Garciadiego-Cázares D; Ortega-Cuellar D; Martínez-López V; Alfaro-Rodríguez A; Evia-Ramírez AN; Ignacio-Mejía I; Vargas-Hernández MA; Bandala C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373348
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological effects of cabergoline against parkinsonism].
Ichikawa K; Kojima M
Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):395-400. PubMed ID: 11436517
[TBL] [Abstract][Full Text] [Related]
13. High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy.
Jung SH; Kim YS; Lee YR; Kim JS
Br J Pharmacol; 2016 Jan; 173(1):15-26. PubMed ID: 26276677
[TBL] [Abstract][Full Text] [Related]
14. Agonistic actions of pergolide on firing activity of dopamine neurons in substantia nigra compacta area.
Zhang XX; Jin GZ; Wei YF
Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):423-7. PubMed ID: 8701759
[TBL] [Abstract][Full Text] [Related]
15. Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline-A study using zebrafish model.
Nathan JR; Lakshmanan G; Michael FM; Seppan P; Ragunathan M
Biomed Pharmacother; 2016 Dec; 84():1406-1418. PubMed ID: 27802896
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor agonists for treating prolactinomas.
Colao A; di Sarno A; Pivonello R; di Somma C; Lombardi G
Expert Opin Investig Drugs; 2002 Jun; 11(6):787-800. PubMed ID: 12036422
[TBL] [Abstract][Full Text] [Related]
17. Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury.
Flashman LA; McDonald BC; Ford JC; Kenny RM; Andrews KD; Saykin AJ; McAllister TW
J Neurotrauma; 2021 Jan; 38(2):225-234. PubMed ID: 32635808
[TBL] [Abstract][Full Text] [Related]
18. Aloe-emodin suppresses hypoxia-induced retinal angiogenesis
Wu J; Ke X; Wang W; Zhang H; Ma N; Fu W; Zhao M; Gao X; Hao X; Zhang Z
Int J Biol Sci; 2016; 12(11):1363-1371. PubMed ID: 27877088
[No Abstract] [Full Text] [Related]
19. von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish.
van Rooijen E; Voest EE; Logister I; Bussmann J; Korving J; van Eeden FJ; Giles RH; Schulte-Merker S
Dis Model Mech; 2010; 3(5-6):343-53. PubMed ID: 20335444
[TBL] [Abstract][Full Text] [Related]
20. Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine-treated rodents.
Miyagi M; Arai N; Taya F; Itoh F; Komatsu Y; Kojima M; Isaji M
Biol Pharm Bull; 1996 Nov; 19(11):1499-502. PubMed ID: 8951172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
